Tags

Type your tag names separated by a space and hit enter

[Stereotactic vacuum core biopsy of clustered microcalcifications classified as B1-RADS 3].
Rofo. 2001 Aug; 173(8):696-701.ROFO

Abstract

PURPOSE

Evaluation of stereotactic vacuum core biopsy of clustered microcalcifications categorized as BI-RADS 3.

MATERIAL AND METHODS

86 patients with microcalcifications BI-RADS 3 (probably benign, < 3% malignant) underwent a stereotactic vacuum core biopsy (Mammotome, Fa. Ethicon Endo-Surgery Breast Care) using a digital stereotactic unit (Mammotest, Fa. Fischer Imaging). The removal of the calcifications was judged by two radiologists in consensus and classified as complete (100%), major (55-99%) or incomplete (< 50%).

RESULTS

4/86 patients could not be evaluated by vacuum core biopsy due to the localization of the microcalcifications close to the skin or lack of detection. In 40/82 cases a complete, in 38/82 a major, and in 4/82 a incomplete removal was achieved. Histology revealed 67 cases of fibrocystic changes, 4 papillomas, 4 fibroadenomas, 4 cases of atypical ductal hyperplasia (ADH), and 3 ductal carcinomas in situ (DCIS), one of these with a minimal-invasive tumor component. Patient with ADH were advised to undergo surgical biopsy. Histology revealed complete removal. 7 patients had complications or side-effects.

CONCLUSIONS

Percutaneous vacuum core biopsy is a reliable minimal-invasive diagnostic method to come to the final diagnosis in patients with clustered microcalcifications categorized BI-RADS 3. However, if malignancy is proven (about 4% of our cases) an open biopsy is necessary.

Links

Publisher Full Text

Authors+Show Affiliations

Obenauer S
Abt. Röntgendiagnostik I, Klinikum der Georg-August-Universität, Göttingen. soben@med.uni-goettingen.de
Fischer U
No affiliation info available
Baum F
No affiliation info available
Dammert S
No affiliation info available
Füzesi L
No affiliation info available
Grabbe E
No affiliation info available

MeSH

AdultAgedBiopsyBreastBreast DiseasesBreast NeoplasmsCalcinosisCarcinoma in SituCarcinoma, Ductal, BreastDiagnosis, DifferentialFemaleFibroadenomaFollow-Up StudiesHumansHyperplasiaMagnetic Resonance ImagingMammographyMiddle AgedPapilloma, IntraductalStereotaxic TechniquesTime Factors

Pub Type(s)

Comparative Study
Journal Article

Language

ger

PubMed ID

11570238

Citation

Obenauer, S, et al. "[Stereotactic Vacuum Core Biopsy of Clustered Microcalcifications Classified as B1-RADS 3]." RoFo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, vol. 173, no. 8, 2001, pp. 696-701.
Obenauer S, Fischer U, Baum F, et al. [Stereotactic vacuum core biopsy of clustered microcalcifications classified as B1-RADS 3]. Rofo. 2001;173(8):696-701.
Obenauer, S., Fischer, U., Baum, F., Dammert, S., Füzesi, L., & Grabbe, E. (2001). [Stereotactic vacuum core biopsy of clustered microcalcifications classified as B1-RADS 3]. RoFo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, 173(8), 696-701.
Obenauer S, et al. [Stereotactic Vacuum Core Biopsy of Clustered Microcalcifications Classified as B1-RADS 3]. Rofo. 2001;173(8):696-701. PubMed PMID: 11570238.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Stereotactic vacuum core biopsy of clustered microcalcifications classified as B1-RADS 3]. AU - Obenauer,S, AU - Fischer,U, AU - Baum,F, AU - Dammert,S, AU - Füzesi,L, AU - Grabbe,E, PY - 2001/9/26/pubmed PY - 2001/10/12/medline PY - 2001/9/26/entrez SP - 696 EP - 701 JF - RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin JO - Rofo VL - 173 IS - 8 N2 - PURPOSE: Evaluation of stereotactic vacuum core biopsy of clustered microcalcifications categorized as BI-RADS 3. MATERIAL AND METHODS: 86 patients with microcalcifications BI-RADS 3 (probably benign, < 3% malignant) underwent a stereotactic vacuum core biopsy (Mammotome, Fa. Ethicon Endo-Surgery Breast Care) using a digital stereotactic unit (Mammotest, Fa. Fischer Imaging). The removal of the calcifications was judged by two radiologists in consensus and classified as complete (100%), major (55-99%) or incomplete (< 50%). RESULTS: 4/86 patients could not be evaluated by vacuum core biopsy due to the localization of the microcalcifications close to the skin or lack of detection. In 40/82 cases a complete, in 38/82 a major, and in 4/82 a incomplete removal was achieved. Histology revealed 67 cases of fibrocystic changes, 4 papillomas, 4 fibroadenomas, 4 cases of atypical ductal hyperplasia (ADH), and 3 ductal carcinomas in situ (DCIS), one of these with a minimal-invasive tumor component. Patient with ADH were advised to undergo surgical biopsy. Histology revealed complete removal. 7 patients had complications or side-effects. CONCLUSIONS: Percutaneous vacuum core biopsy is a reliable minimal-invasive diagnostic method to come to the final diagnosis in patients with clustered microcalcifications categorized BI-RADS 3. However, if malignancy is proven (about 4% of our cases) an open biopsy is necessary. SN - 1438-9029 UR - https://www.unboundmedicine.com/medline/citation/11570238/[Stereotactic_vacuum_core_biopsy_of_clustered_microcalcifications_classified_as_B1_RADS_3]_ L2 - https://www.thieme-connect.com/DOI/DOI?10.1055/s-2001-16398 DB - PRIME DP - Unbound Medicine ER -